Barrier-breaking #celltherapy company. Evaluating the use of your own cells to intelligently heal. Strong trial results. In Phase III for knee #osteoarthritis.
We reached a research milestone of halfway enrollment in our #FDA compliant, multi-site, double-blinded, randomized, placebo-controlled #clinicaltrial investigating autologous, adipose-derived #SVF cells to potentially improve #kneeOA symptoms.
#CEO Bill Cimino, Ph.D, #keynoted at the @LASPS September meeting. He covered the fast growing #biologics, #cellulartherapy field, covering evidence-based outcomes and #clinicalresults.
Visit our website to learn more about GID BIO’s approach to clinical evidence.
The newest member of our team, Sandeep Samudre, Ph.D., MPH, is the director of clinical operations. He has 20+ years of experience in #clinicaltrials and #trialops.
Learn more about Sandeep in this blog.
Dr. Manish Gupta joins as the newest principal investigator in an FDA-compliant trial evaluating our cellular therapy for the treatment of #kneeosteoarthritis. He leads the team at Advanced Research Florida. #orthotwitter@diegoame@joshalpert